NUZOLVENCE Trademark

Trademark Overview


On Wednesday, October 1, 2025, a trademark application was filed for NUZOLVENCE with the United States Patent and Trademark Office. The USPTO has given the NUZOLVENCE trademark a serial number of 99423851. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, June 1, 2026. This trademark is owned by Entasis Therapeutics (Ireland) Limited. The NUZOLVENCE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Antibiotics; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of gonorrhea; Pharmaceutical preparations for the treatment of sexually transmitted diseases

Providing medical information in the field of infectious diseases; Providing medical information in the field of gonorrhea; Providing medical information in the field of sexually transmitted diseases

General Information


Serial Number99423851
Word MarkNUZOLVENCE
Filing DateWednesday, October 1, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, June 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 23, 2026

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a design comprising circle in the center surrounded by an inner ring of four partial circles and four large circles, and an outer ring comprising four medium circles and eight small circles, to the left of the stylized term "NUZOLVENCE".
Goods and ServicesAntibiotics; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of gonorrhea; Pharmaceutical preparations for the treatment of sexually transmitted diseases
Goods and ServicesProviding medical information in the field of infectious diseases; Providing medical information in the field of gonorrhea; Providing medical information in the field of sexually transmitted diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 1, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 1, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEntasis Therapeutics (Ireland) Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 4
IE

Trademark Events


Event DateEvent Description
Wednesday, October 1, 2025NEW APPLICATION ENTERED
Wednesday, October 1, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 19, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 19, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, February 20, 2026ASSIGNED TO EXAMINER
Friday, February 20, 2026NON-FINAL ACTION WRITTEN
Friday, February 20, 2026NON-FINAL ACTION E-MAILED
Friday, February 20, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 19, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 19, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 19, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 22, 2026EXAMINERS AMENDMENT -WRITTEN
Friday, May 22, 2026EXAMINERS AMENDMENT E-MAILED
Friday, May 22, 2026EXAMINER'S AMENDMENT ENTERED
Friday, May 22, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 22, 2026APPROVED FOR PUB - PRINCIPAL REGISTER